Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001625101-21-000023
Filing Date
2021-05-10
Accepted
2021-05-10 16:38:09
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q plse-20210331x10q.htm   iXBRL 10-Q 2389733
2 EX-31.1 plse-20210331xex31_1.htm EX-31.1 23815
3 EX-31.2 plse-20210331xex31_2.htm EX-31.2 23991
4 EX-32.1 plse-20210331xex32_1.htm EX-32.1 21501
  Complete submission text file 0001625101-21-000023.txt   7563946

Data Files

Seq Description Document Type Size
5 EX-101.SCH plse-20210331.xsd EX-101.SCH 39337
6 EX-101.CAL plse-20210331_cal.xml EX-101.CAL 51573
7 EX-101.DEF plse-20210331_def.xml EX-101.DEF 134869
8 EX-101.LAB plse-20210331_lab.xml EX-101.LAB 325904
9 EX-101.PRE plse-20210331_pre.xml EX-101.PRE 303744
10 EXTRACTED XBRL INSTANCE DOCUMENT plse-20210331x10q_htm.xml XML 1343255
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37744 | Film No.: 21907840
SIC: 3841 Surgical & Medical Instruments & Apparatus